Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment

Compared with paclitaxel, sirolimus has been more used in the treatment of vascular restenosis gradually as an anti-proliferative drug, but few basic studies have elucidated its mechanism. The anti-proliferative effects of sirolimus or paclitaxel have been demonstrated by numerous studies under norm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Youlu, Zeng, Yong, Zhu, Xiaowei, Miao, Lifu, Liang, Xiaoyu, Duan, Jianwei, Li, Huiyang, Tian, Xinxin, Pang, Liyun, Wei, Yongxiang, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530254/
https://www.ncbi.nlm.nih.gov/pubmed/33024904
http://dx.doi.org/10.1016/j.bioactmat.2020.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530254/
https://www.ncbi.nlm.nih.gov/pubmed/33024904
http://dx.doi.org/10.1016/j.bioactmat.2020.09.005

Ejemplares similares